Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06948851 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

New Postoperative Intraretinal Cystoid Changes After Vitrectomy With Membrane Peeling Due to Epiretinal Membranes

StatusActive, Not Recruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated April 29, 2025 (before its estimated April 30, 2025 completion). Its status may not reflect the trial's current state.

Record History

  1. Study First Submitted
Epiretinal membranes (ERM) are a macular disorder leading to metamorphopsia and a decrease in visual acuity. Peeling of ERM during vitrectomy is, up to date, the only possible treatment option, opening chances for improvements of visual acuity and metamorphopsia. Occurrence of new intraretinal cystoid changes was described to be associated with a lower level of visual acuity after surgery, compared to patients, that never had intraretinal cystoid changes Aim of our study was to analyze development of new intraretinal cystoid changes after vitrectomy with membrane peeling with respect to postsurgical treatment strategies.
Trial Details
NCT Number NCT06948851
Lead Sponsor Prim. Prof. Dr. Oliver Findl, MBA
Conditions
(from sponsor)		 Epiretinal Membrane
Related terms Epiretinal Membrane
Enrollment 114 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov